Hound Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$949K Sell
2,453
-1,482
-38% -$550K 0.11% 29
2026
Q1
$1.15M Buy
+3,935
New +$1.29M 0.14% 32

Other funds holding ELV

Hound Partners's ELV Position: Q2 2026 in Review

Hound Partners reduced its Elevance Health (ELV) stake by 38% in Q2 2026, selling an estimated $550K and leaving 2,453 shares worth $949K. The position accounts for 0.11% of the portfolio, ranked #29.

Hound Partners first reported a position in ELV in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.15M in Q1 2026. 1,611 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Hound Partners held 2,453 shares of Elevance Health worth $949K as of Q2 2026.
  • Hound Partners sold 1,482 Elevance Health shares in Q2 2026, an estimated $550K.
  • Elevance Health made up 0.11% of Hound Partners's portfolio in Q2 2026, its #29 holding.
  • Hound Partners first reported a position in Elevance Health in Q1 2026 and has held it in 2 quarters since.
  • Hound Partners's Elevance Health position peaked at $1.15M in Q1 2026.
  • 1,611 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Hound Partners's 13F filing for Q2 2026, filed 14 Aug 2026.